Real-World Patient Experience of Long-Term Hybrid Closed-Loop Insulin Pump Use.
Sign Up to like & getrecommendations! Published in 2021 at "Canadian journal of diabetes"
DOI: 10.1016/j.jcjd.2021.02.006
Abstract: OBJECTIVES Understanding of patient experiences and adaptations to hybrid closed-loop (HCL) pumps beyond the confines of short-term clinical trials is needed to inform best practices surrounding this emerging technology. We investigated long-term, real-world patient experiences… read more here.
Keywords: real world; auto mode; auto; term ... See more keywords
Increased proportion of time in hybrid closed‐loop “Auto Mode” is associated with improved glycaemic control for adolescent and young patients with adult type 1 diabetes using the MiniMed 670G insulin pump
Sign Up to like & getrecommendations! Published in 2019 at "Diabetes"
DOI: 10.1111/dom.13912
Abstract: The Medtronic MiniMed 670G system delivers insulin to patients with type 1 diabetes mellitus (T1DM) using either its hybrid closed‐loop (HCL) “Auto Mode” feature or an open‐loop mode. In this retrospective, cross‐sectional analysis, we quantified… read more here.
Keywords: auto; auto mode; time; type diabetes ... See more keywords
Real-World Data from the MiniMed™ 670G System Commercial Launch
Sign Up to like & getrecommendations! Published in 2018 at "Diabetes"
DOI: 10.2337/db18-960-p
Abstract: The Medtronic MiniMed™ 670G hybrid closed-loop system with SmartGuard™ technology, which automatically adjusts basal insulin delivery, was released for commercial use in the U.S. in March 2017. Data from the first 13,9patients to use the… read more here.
Keywords: mode; system; auto mode; time ... See more keywords